Wed, Nov 04, 2026 - Page 36
24697 indexed SquawkNews stories from this UTC day. Showing 4201-4320.
M
AppLovin Announces Third-Quarter 2026 Financial Results
AppLovin said it posted a financial update for the quarter ended September 30, 2026.
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Permian Resources Raises 2026 Oil Target by 13.5 MBbls/d
Q3 oil production rose 5% quarter over quarter to 208,029 Bbls/d, and adjusted free cash flow was $846 million. The company also agreed to acquire Ridge Runner for approximately $1.025 billion.
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Lumine Group Announces Third-Quarter Results for Period Ended September 30, 2026
Lumine Group announced results for the third quarter ended September 30, 2026; the release provides no financial figures or catalyst details in the supplied text.
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
Magnite Reports $34M Net Income for Q3
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
Magnite Reports Third-Quarter Revenue of $204.2 Million
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Power Integrations Reports Q3 Gross Profit of $69.717 Million
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
MercadoLibre Q3 net profit $448 million, below $476 million IBES estimate
MercadoLibre reported Q3 net profit of $448 million, compared with the $476 million IBES estimate.
EQUITY | Nov 04, 2026, 09:05 PM UTC
L
Outset Medical reports Q3 operating expenses of $25.94 million
EARNINGS | Nov 04, 2026, 09:05 PM UTC
H
$QCOM Qualcomm Q4 Earnings
Adjusted EPS $2.17, est. $2.16 Adjusted revenue $10.44B, est. $10.12B FY capex $2.49B, est. $1.86B Sees Q1 adjusted EPS $2.15 to $2.35, est. $2.32 Sees Q1 revenue $10.4B to $11.2B, est. $10.55B
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
Progyny Q3 Pretax Profit $36.416 Million
EQUITY | Nov 04, 2026, 09:05 PM UTC
L
Pennant Group Reports Third-Quarter EPS
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Chesapeake Granite Wash Trust Sets $0.0154 Per-Unit Distribution
The distribution is for the quarter ended September 30, 2026. Payment is scheduled for November 30 to holders of record November 19; no prior-period comparison was provided.
EQUITY | Nov 04, 2026, 09:05 PM UTC
L
Pennant Group reports third-quarter adjusted EPS
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
Warrior Reports Third-Quarter 2026 Results
Warrior Met Coal announced results for the third quarter of 2026.
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Purple Innovation Reports Third-Quarter Loss per Share
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Progyny Announces Third-Quarter 2026 Results
Progyny reported record third-quarter results for revenue, gross profit, adjusted EBITDA and net income.
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Allegiant Travel Q3 Adjusted EPS USD -0.03 Versus IBES Estimate USD -0.53
Allegiant Travel reported Q3 adjusted EPS of USD -0.03, compared with the IBES estimate of USD -0.53.
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Personalis Reports Q3 Income From Operations
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
PTC Q4 Revenue Reaches USD 673 Million
PTC reported Q4 revenue of USD 673 million, versus the IBES estimate of USD 661.7 million.
EQUITY | Nov 04, 2026, 09:05 PM UTC
L
Asure Software Sets November and December 2026 Investor Conference Schedule
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Coherent Reports 1Q EPS of $1.90
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Lumine Group Reports Q3 Net Income of USD 25.5 Million
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
NAB FY Net Interest Margin Rises to 1.80% From 1.74%
NAB reported a fiscal-year net interest margin of 1.80%, versus 1.74%.
EQUITY | Nov 04, 2026, 09:05 PM UTC
L
AGL Private Credit Income files Form 10-Q
AGL Private Credit Income filed a Form 10-Q for the period ended September 30.
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Permian Resources Reports Third-Quarter Results, Updates 2026 Guidance
Permian Resources announced third-quarter 2026 financial and operational results and revised its 2026 guidance.
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Lumen Technologies Q3 Adjusted EPS vs. IBES Estimate
Lumen Technologies reported Q3 adjusted EPS, compared with the IBES estimate.
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
Xencor Reports Q3 Revenue of $116.5 Million, Net Income of $39.4 Million
Xencor reported diluted earnings of $0.50 per share. Revenue was $21.0 million and net income was a loss of $6.0 million in the year-earlier quarter.
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Veeco Instruments Reports Third-Quarter Sales of $209.4M
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
Niagen Bioscience Reports Third-Quarter 2026 Financial Results
Niagen Bioscience reported financial results for the third quarter of 2026; the supplied body is truncated before any figures or details.
EQUITY | Nov 04, 2026, 09:05 PM UTC
L
Caris Life Sciences Reports Third-Quarter EPS
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Chesapeake Granite Wash Trust Announces $0.0154 Per-Unit Distribution
The trust announced a common unit distribution of $0.0154 for the quarter ended September 30, 2026, primarily related to production from June 1 through August 31, 2026.
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Hamilton Beach Brands Reports Third-Quarter Net Income of $3.54 Million
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
Power Integrations Reports Q3 Operating Income of $19.125 Million
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Moleculin Biotech to Present Annamycin Phase 2/3 Data at ASH
Moleculin Biotech says it will present interim Annamycin trial data at ASH, including higher remission rates in treatment arms than placebo.
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Revolution Medicines Receives FDA Approval and Launches RASONQUE
Revolution Medicines received U.S. FDA approval and launched RASONQUE (daraxonrasib) for adults with metastatic disease. The provided text does not specify the disease.
EQUITY | Nov 04, 2026, 09:05 PM UTC
H
$ARM Arm Holdings Q2 Earnings
EPS $0.12 Adjusted EPS $0.52, est. $0.47 Revenue $1.44B, est. $1.38B Adjusted net income $566M, est. $514.2M Adjusted operating income $638M, est. $575.7M Adjusted gross margin 97.9%, est. 98% Royalty revenue $773M, est.
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Personalis Reports Q3 Net Income
EARNINGS | Nov 04, 2026, 09:05 PM UTC
M
Lumen Technologies Q3 Revenue Is $2.72 Billion
Q3 revenue was $2.72 billion, compared with the IBES estimate of $2.732 billion.
EQUITY | Nov 04, 2026, 09:05 PM UTC
M
Microsoft Issues $25 Billion in Notes Maturing From 2028 to 2066
Microsoft issued $25 billion in fixed- and floating-rate notes, with maturities ranging from 2028 to 2066.
EQUITY | Nov 04, 2026, 09:05 PM UTC
L
Envista Holdings Reports Third-Quarter Net of $508.3 Million
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Envista Holdings Reports Third-Quarter Adjusted EPS
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Progyny Reports Q3 Net Income of USD 26.252 Million
EARNINGS | Nov 04, 2026, 09:05 PM UTC
L
Clipper Realty Reports Q3 Income From Operations of $9.9 Million
EARNINGS | Nov 04, 2026, 09:04 PM UTC
L
Lumen Technologies reports Q3 EPS of USD -0.26
EARNINGS | Nov 04, 2026, 09:04 PM UTC
L
8x8 Cites AI and Frontline Teams as Drivers of Q2 CX Growth
8x8 says customers are bringing AI into live conversations and reaching people on their preferred channels.
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Deluxe Q3 Adjusted EPS Is $1.06 Versus $0.95 Estimate
Deluxe reported Q3 EPS of $0.28, while adjusted EPS was $1.06 against an IBES estimate of $0.95.
EARNINGS | Nov 04, 2026, 09:04 PM UTC
L
Cabaletta Bio Reports Inducement Grants
Cabaletta Bio reports inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
Cirrus Logic Q2 operating expenses total $168.2 million
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
HMH Holding Announces Third-Quarter 2026 Results
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
BRIEF-Niagen Bioscience Inc Q3 Sales USD 27.192 Million Vs. IBES Estimate USD 32.1 Million
Nov 04 (Reuters) - Niagen Bioscience Inc Q3 net income USD -1.173 million.
EARNINGS | Nov 04, 2026, 09:04 PM UTC
M
Outset Medical Reports Q3 Gross Margin of 40.7%
EARNINGS | Nov 04, 2026, 09:04 PM UTC
L
Cabaletta Bio Reports Inducement Grants
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
Qualcomm Sees 1Q EPS of $1.03–$1.23
EARNINGS | Nov 04, 2026, 09:04 PM UTC
M
Onterris Reports Q3 Revenue of USD 203.044 Million
Q3 revenue was USD 203.044 million versus the IBES estimate of USD 197.1 million. Income from operations was USD 12.282 million.
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
Permian Resources Declares Quarterly Cash Dividend
MIDLAND, Texas--(BUSINESS WIRE)-- Permian Resources Corporation (“Permian Resources” or the “Company
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Arm Reports Fiscal Q2 2027 Results
Arm published a shareholder letter containing results for its fiscal second quarter, which ended Sept. 30, 2026.
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Janus Living Launches Public Offering of 25 Million Class A-1 Shares
Janus Living announced a public offering of 25,000,000 shares of its Class A-1 common stock under a registration statement filed with the SEC.
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Dianthus Therapeutics Reports Q3 2026 Financial Results
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Expedia Q3 Gross Bookings Reach $34.01 Billion, Beat Estimate
Expedia Group reported Q3 gross bookings of $34.01 billion, above the IBES estimate of $32.22 billion; no catalyst was supplied.
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Arm Beats Second-Quarter Revenue Estimates on AI and Data-Center Demand
Arm Holdings said revenue exceeded Wall Street estimates, driven by higher royalty payments and licensing fees from customers deploying its chip architecture in AI-related computing products.
EARNINGS | Nov 04, 2026, 09:04 PM UTC
L
Dianthus Therapeutics Reports Q3 Operating Income
Dianthus Therapeutics reported Q3 income from operations.
EARNINGS | Nov 04, 2026, 09:04 PM UTC
L
Lumine Group Q3 Operating Income USD 85.5 Million
EARNINGS | Nov 04, 2026, 09:04 PM UTC
L
Sinclair Says It Will Not Separate Ventures in Standalone Transaction
Sinclair says it has determined not to separate its ventures in a standalone transaction at this time.
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
Niagen Bioscience Files Form 10-Q for Quarter Ended Sept. 30
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
Electronic Arts Takes Bondholder Dispute to Court
Electronic Arts is taking a dispute with bondholders to court. The wire update says U.S. Bank Trust declined to comment.
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
Prospect Capital files Form 424B3
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
ARKO Petroleum files Form 8-K
ARKO Petroleum Corp. filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Cirrus Logic Q2 Adjusted EPS $2.70 vs. IBES Estimate $2.42
EARNINGS | Nov 04, 2026, 09:04 PM UTC
L
BETA Technologies Form 144 Filed by Clark Kyle
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
NAB FY Common Equity Tier 1 ratio at 11.87% vs 11.70%
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
Syndax Pharmaceuticals Reports Inducement Grants
Syndax Pharmaceuticals reports inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Lumine Group Revenue Rises 55% to $289.9 Million in Q3
Revenue increased 55% year over year to $289.9 million. Operating income grew 31% year over year; no operating income amount was provided.
EARNINGS | Nov 04, 2026, 09:04 PM UTC
M
PTC Reports Q4 Adjusted EPS of USD 2.03 Versus USD 1.96 Estimate
PTC also reported a Q4 operating margin of 32%.
EARNINGS | Nov 04, 2026, 09:04 PM UTC
M
Allegiant Travel Reports Third-Quarter Revenue of $961.6 Million
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Expedia Group Reports Third-Quarter 2026 Results
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
Stellantis Appoints Pablo Di Si COO for North America and American Brands
Di Si joins the Stellantis Leadership Team and will report directly to CEO Antonio Filosa.
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Revolution Medicines Reports $407.5M Third-Quarter Loss
EQUITY | Nov 04, 2026, 09:04 PM UTC
L
Praxis Precision Medicines Announces Inducement Grants
Praxis Precision Medicines announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Nov 04, 2026, 09:04 PM UTC
M
Magnolia Oil & Gas Reports Q3 EPS of USD 0.35
Magnolia Oil & Gas reported Q3 capex of USD 147.4 million.
EARNINGS | Nov 04, 2026, 09:04 PM UTC
M
Edgewise Therapeutics Reports Q3 Net Income of USD 1,166.151 Million
Reuters also reports Q3 basic EPS of USD 10.71.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
Microsoft raises $25b in 10-tranche bond offering. $MSFT
Microsoft raises $25b in 10-tranche bond offering. $MSFT
NEWS | Nov 04, 2026, 09:03 PM UTC
L
Allegiant Travel files Form 8-K
Allegiant Travel filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
Qualcomm Forecasts Upbeat Sales on Non-Smartphone Segment Strength
Qualcomm forecast first-quarter revenue above Wall Street estimates, citing strength in automotive and internet of things that is helping cushion sluggish smartphone-chip demand.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
Alpha Teknova Reports Q3 EPS of USD -0.06
Alpha Teknova reported Q3 gross profit of USD 4.826 million.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
M
Expedia Group Q3 revenue reaches $4.94 billion
Expedia Group reported Q3 revenue of $4.94 billion versus the IBES estimate of $4.74 billion.
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
Clipper Realty Reports Q3 Revenue of USD 40.5 Million
Reuters also reports a Q3 dividend of USD 0.095.
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Outset Medical Reports Q3 Net Income
Outset Medical reported Q3 gross profit of USD 13.671 million.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
M
PTC Q4 Adjusted EPS $2.03 vs. IBES Estimate $1.96
EARNINGS | Nov 04, 2026, 09:03 PM UTC
M
Sunrun Q3 Revenue Reaches $1,099.5 Million vs. IBES Estimate of $774 Million
Sunrun reported Q3 operating expenses of $946 million.
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
Maravai LifeSciences Q3 Revenue Reaches $45.9 Million
Q3 adjusted EBITDA was $5.8 million, versus the IBES estimate of $512.9 thousand.
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
PTC Reports Q4 EPS of USD 1.44
EARNINGS | Nov 04, 2026, 09:03 PM UTC
M
Allegiant Travel Expects Q4 Adjusted EPS of $1.00–$1.50
EARNINGS | Nov 04, 2026, 09:03 PM UTC
M
Sinclair 3Q Political Advertising Revenue Rises 55% to $136 Million
Sinclair reported $136 million in third-quarter political advertising revenue, up 55% versus 3Q22.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
PTC Reports Q4 Operating Margin of 32%
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
Niagen Bioscience files Form 8-K
Niagen Bioscience filed a Form 8-K on November 4.
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Praxis Precision Medicines Announces Inducement Grants
Praxis Precision Medicines announced inducement grants under Nasdaq Listing Rule 5635(c)(4).
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
NeoVolta Form 4 Filed by Susan H. Snow
A Form 4 for NeoVolta Inc. was filed by Susan H. Snow on November 4.
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Magnachip Semiconductor Q3 Net Income USD -12.543 Million
Magnachip Semiconductor reported Q3 gross margin of 14%.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
Dianthus Therapeutics Reports Q3 Operating Expenses of $59.682 Million
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
National Australia Bank FY Cash Earnings A$6.14B
National Australia Bank reported FY cash earnings of A$6.14B, versus A$7.09B.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
Liquidity Services Form 4 Filed by John Daunt
A Form 4 for Liquidity Services was filed by John Daunt for Nov. 2.
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Personalis Reports Q3 Net Income
Personalis reported Q3 basic EPS of USD -0.32.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
Allegiant Remains Confident in 2026 Adjusted EPS Guidance Above $6
Allegiant Travel Company said it remains confident in 2026 fiscal-year adjusted earnings per share guidance of greater than $6.00, despite elevated fuel costs.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
McGrath RentCorp Issues $75 Million in 6.53% Senior Notes
The notes mature November 2, 2031. An amendment increases the company’s private shelf facility to $350 million and raises certain default thresholds.
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
MercadoLibre Reports Third-Quarter 2026 Financial Results
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
BioCryst to Present at Upcoming Investor Conferences
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Linamar Reports Third-Quarter EPS of C$2.51
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
HMH Holding Files 8K - Operations And Financial Condition >HMH
HMH Holding Inc. (HMH) filed a Form 8K - Operations and Financial Condition - with the U.S Securities and Exchange Commission on November 04, 2026.On November 4, 2026, HMH Holding Inc. issued a news release reporting its
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
ARKO Corp. files Form 8-K
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Terreno Realty files Form 10-Q for quarter ended Sept. 30
Terreno Realty Corp filed a Form 10-Q for the period ended Sept. 30.
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Edgewise Therapeutics Reports Q3 Operating Expenses of $46.143 Million
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
Sezzle Reports Third-Quarter 2026 Results
Sezzle reported third-quarter 2026 results. Total transaction volume reached $1.4 billion, up 34.9% year over year.
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Borje Ekholm Files Form 3 for Nasdaq, Inc.
The filing is dated November 4 and relates to November 1.
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Fate Therapeutics Form 4 Filed by Kamal Adawi
A Form 4 for Fate Therapeutics was filed by Kamal Adawi for November 3.
EQUITY | Nov 04, 2026, 09:03 PM UTC
L
Olema Oncology to Present Combination Data at Breast Cancer Symposium
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
PureCycle Technologies Reports Third-Quarter 2026 Results
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
Onterris Reports Third-Quarter Results, Reiterates 2026 Guidance
Onterris also announced completed acquisitions and provided an update on its board-led strategic review process.
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
Sunrun Reports Third-Quarter 2026 Financial Results
Sunrun reported third-quarter 2026 financial results. The company cited continued sales growth in its direct business and Aggregate Subscriber Value of approximately $1.
EQUITY | Nov 04, 2026, 09:03 PM UTC
M
National Australia Bank FY Cash Earnings AUD 6,141 Million
FY cash earnings were AUD 6,141 million, versus the IBES estimate of AUD 6,510 million.
EARNINGS | Nov 04, 2026, 09:03 PM UTC
L
Expedia Declares Quarterly Cash Dividend of $0.48 Per Share
EQUITY | Nov 04, 2026, 09:03 PM UTC